vida: research 2026 04 29 #5437

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 04:48:33 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 04:49 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 04:49 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, drawing on specific data points like MSSP savings figures, GLP-1 coverage declines, and MHPAEA report findings.
  2. Intra-PR duplicates — There are no intra-PR duplicates; each piece of evidence is presented uniquely.
  3. Confidence calibration — The confidence calibration is appropriate, with Belief 3 being strengthened due to new quantitative evidence and the GLP-1 claim identified as needing enrichment.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, drawing on specific data points like MSSP savings figures, GLP-1 coverage declines, and MHPAEA report findings. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; each piece of evidence is presented uniquely. 3. **Confidence calibration** — The confidence calibration is appropriate, with Belief 3 being strengthened due to new quantitative evidence and the GLP-1 claim identified as needing enrichment. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Vida Research Journal Session 2026-04-29

Criterion-by-Criterion Evaluation

  1. Schema — All files in inbox/queue/ are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR.

  2. Duplicate/redundancy — This PR adds a new research journal session synthesizing evidence from 11 new sources; no enrichments to existing claims are present in this diff, so no duplicate injection issue exists (the session notes potential enrichment needs but doesn't execute them).

  3. Confidence — No claims are modified or created in this PR (only agent documentation and sources added), so there are no confidence levels to evaluate.

  4. Wiki links — The research journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims without providing wiki links, but these are narrative references in agent documentation rather than formal claim relationships, so this is acceptable for journal format.

  5. Source quality — The 11 sources cited span credible healthcare policy outlets (CMS official reports, Health Affairs, 9amHealth industry newsletter, HCPlan data) appropriate for VBC/market competition analysis, with government data (MSSP reports, MHPAEA) providing primary evidence for the core structural claims.

  6. Specificity — No new claims are created in this PR; the research journal makes falsifiable analytical statements ("market competition mechanisms are MARGINAL," "full capitation DOUBLED from 7% to 14%") but these are agent reasoning documentation rather than KB claims subject to specificity requirements.

Additional Observations

The research journal session documents a disconfirmation attempt that failed (strengthening Belief 3 instead), which demonstrates appropriate epistemic rigor. The quantitative precision added (MSSP $2.48B savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives) provides falsifiable benchmarks for future evaluation. The session correctly identifies an enrichment need for existing GLP-1 claims but doesn't prematurely modify them without proper claim workflow.

# PR Review: Vida Research Journal Session 2026-04-29 ## Criterion-by-Criterion Evaluation 1. **Schema** — All files in `inbox/queue/` are sources (not claims or entities), so they correctly lack claim frontmatter fields; the research journal and musings files are agent documentation without schema requirements, so no schema violations exist in this PR. 2. **Duplicate/redundancy** — This PR adds a new research journal session synthesizing evidence from 11 new sources; no enrichments to existing claims are present in this diff, so no duplicate injection issue exists (the session notes potential enrichment needs but doesn't execute them). 3. **Confidence** — No claims are modified or created in this PR (only agent documentation and sources added), so there are no confidence levels to evaluate. 4. **Wiki links** — The research journal references "Session 30's payer mandate acceleration story" and mentions existing GLP-1 claims without providing [[wiki links]], but these are narrative references in agent documentation rather than formal claim relationships, so this is acceptable for journal format. 5. **Source quality** — The 11 sources cited span credible healthcare policy outlets (CMS official reports, Health Affairs, 9amHealth industry newsletter, HCPlan data) appropriate for VBC/market competition analysis, with government data (MSSP reports, MHPAEA) providing primary evidence for the core structural claims. 6. **Specificity** — No new claims are created in this PR; the research journal makes falsifiable analytical statements ("market competition mechanisms are MARGINAL," "full capitation DOUBLED from 7% to 14%") but these are agent reasoning documentation rather than KB claims subject to specificity requirements. ## Additional Observations The research journal session documents a disconfirmation attempt that failed (strengthening Belief 3 instead), which demonstrates appropriate epistemic rigor. The quantitative precision added (MSSP $2.48B savings, 7%→14% capitation growth, 3.6M→2.8M GLP-1 covered lives) provides falsifiable benchmarks for future evaluation. The session correctly identifies an enrichment need for existing GLP-1 claims but doesn't prematurely modify them without proper claim workflow. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 04:50:08 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 04:50:09 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 04:52:05 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.